
To evaluate the contribution of baseline and longitudinal changes in cardiometabolic health (CMH) towards heart failure (HF) risk among adults with type 2 diabetes (T2D). Participants of the Look AHEAD trial with T2D and without prevalent HF were included. Achieving target levels of more CMH parameters at baseline and sustained improvements were associated with lower HF risk in T2D.
Like
Save
Share